Dow Future Option Chain Free Gift Nifty Live X

Molbio Diagnostics IPO GMP Today, Grey Market Premium 2026

Molbio Diagnostics IPO will hit the market on August 10, 2026, and closes on August 12, 2026. The Molbio Diagnostics IPO GMP Kostak rate and subject to Sauda updated as of today. The Molbio Diagnostics IPO GMP (Grey Market Premium) has started with low premium rates at this time, but as some trending movement is possible soon, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check Molbio Diagnostics IPO subscription status here.

Molbio Diagnostics IPO GMP

Molbio Diagnostics Limited is a healthcare technology company specializing in the development and production of advanced point-of-care molecular diagnostic solutions. Its flagship Truenat platform is a compact, battery-powered PCR testing system that delivers fast and reliable results, making it ideal for remote and resource-constrained locations.

The company provides diagnostic tests for more than 30 infectious and chronic diseases, including tuberculosis, HIV, COVID-19, hepatitis, and HPV. With six manufacturing facilities in India and a presence in over 90 countries, Molbio serves hospitals, laboratories, healthcare agencies, and government programs while driving innovation through strong research, patented technologies, and global quality certifications.

Molbio Diagnostics IPO Issue size of ₹940.00 Crores, in which Fresh Issue of ₹200.00 Crores and Offer For Sale of ₹740.00 Crores and issue price band has been fixed at ₹768 to ₹807 Per Share. The IPO will be listed on August 17, 2026, NSE and BSE.

What is Molbio Diagnostics IPO GMP Today?

  • The Molbio Diagnostics IPO GMP Today Or Grey Market Premium is ₹132.

Molbio Diagnostics IPO GMP Today Live :

DATE PRICE GMP EST. P/L

Disclaimer: IPO GMP is an unofficial market indicator based on market sentiment and is for informational purposes only; actual listing price may vary.

IPO GMP Facts
IPO GMP Facts :
  • The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
  • The GMP is also likely to be higher for IPOs that are heavily subscribed.
  • It is important to do your own research before investing in an IPO, regardless of the GMP.
  • The IPO GMP is estimated considering market volatility, demand, supply, underwriting conditions, legal risks, and potential dilution.
  • The Grey Market Premium (GMP) is unofficial and is not regulated by SEBI.
  • Actual listing price may be higher or lower than the estimated listing price.
  • GMP fluctuates continuously until the listing day based on overall stock market sentiment.
  • A negative GMP indicates that the IPO might list at a discount below its issue price.
  • Grey market trading operates entirely on cash/over-the-counter trust and involves no official stock exchange.
  • Institutional subscription numbers (QIBs) often have a direct impact on driving the final GMP trends.
⚠ IPO GMP Disclaimer
  • GMP is not an indicator of the final listing price: Grey Market Premium (GMP) reflects unofficial market sentiment only. The final listing price depends on demand, market conditions, and company fundamentals.
  • GMP can be volatile: GMP may rise or fall significantly before the IPO listing depending on investor sentiment and market activity.
  • No guarantee of listing gains: A high GMP does not guarantee listing profits, and a negative GMP does not necessarily mean the IPO will list at a loss.
  • Investing in IPOs involves risk: Investors should evaluate the company’s financials, valuation, business model, and risk factors before investing.
  • Risk Factors: Market volatility, economic conditions, regulatory changes, and company performance can affect IPO listing performance.
  • Warning: IPO GMP data is purely indicative and should not be considered as a reliable basis for investment decisions. It does not guarantee actual listing performance or returns.
  • Use GMP only as a reference: GMP is unofficial, not regulated by SEBI, and should not be considered investment advice.

Disclaimer: Stock Market Investments are Subject to Market risks, read all scheme Related Document Carefully Before Investing.

Molbio Diagnostics IPO GMP Today, Grey Market Premium 2026

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top